Impact of Epstein-Barr virus infection on the development and prognosis of allergic purpura
DOI:
https://doi.org/10.3855/jidc.21020Keywords:
EBV, allergic, HSP, HSPN, characteristics, prognosisAbstract
Introduction: This study aimed to examine the impact of Epstein-Barr virus (EBV) infection on the occurrence and prognosis of Henoch-Schönlein purpura (HSP).
Methodology: A total of 120 children diagnosed with HSP were selected as the experimental group, and 100 healthy children who underwent physical examinations were the control group. We compared renal function markers and quantified 24-hour urine protein in HSP children with different EBV infection statuses, and analyzed the association between EBV infection and Henoch-Schönlein purpura nephritis (HSPN).
Results: The detection rate of EBV-DNA load in the experimental group (30.83%) was significantly higher than that in the control group (10.00%) (p < 0.05). Among children with HSP, the detection rate of EBV-DNA load was significantly higher in those with abdominal involvement compared to those with joint or mixed types (p < 0.05). Serum levels of serum creatinine, blood urea nitrogen, and urine protein quantification were significantly higher in the EBV-positive group than in the EBV-negative group (p < 0.05). The detection rate of EBV-DNA load was significantly higher in the HSPN group compared to the non-HSPN group (p < 0.05). The detection rate of EBV-DNA load was significantly higher in the recurrence group than in the non-recurrence group (p < 0.05), and it was also higher in the relapse group compared to the non-relapse group (p < 0.05).
Conclusions: EBV infection is associated with the development of HSP; and gastrointestinal, joint, and renal damage. It is also an early warning sign for disease recurrence, which highlights its clinical significance.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Zinian Zhao, Ying Zhang, Jing Han, Rong Ren, Guangming Li , Jinyu Yang

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

